The global flow diversion aneurysm treatment market is forecast to grow at a CAGR of 14.55% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: Rise in demand for intracranial stenting procedures will be a key trend for market growth. With the increase in cases of cerebral aneurysm worldwide, the demand for intracranial stenting procedures is also witnessing an increase. The use of stents gives better navigability in tortuous vessels for optimal cerebral circulation. The introduction of new intracranial devices with flow diverters is highly feasible with complete occlusion rates, and intraoperative neurophysiological monitoring systems help in continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery. This has fueled a significant demand for intracranial stenting procedures.
According to the report, increase in demand for minimally invasive endovascular surgeries will be a key driver for market growth. Minimally invasive endovascular surgeries reduce the duration of hospital stay, allowing a patient to recover faster, and this also translates into better utilization of healthcare resources at a lower cost. In addition, as these surgeries are performed with minute incisions in the body to treat blockages in arteries they do not leave any visible scars.
The neuro-endovascular coiling surgeries are conducted by using a minimally invasive endovascular technique. These procedures are possible even in individuals with high risk of aneurysm rupture. Also, these surgeries can be carried out in ASCs. These advantages are expected to increase the demand for these procedures and contribute to market growth during the forecast period.
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Evolution of treatment for intracranial aneurysm
PART 04: Market research methodology
PART 05: Introduction
PART 06: Market landscape
PART 07: Ongoing clinical trials and approved indications for flow diverters
PART 08: Evolution of endovascular aneurysm treatment